BeOne Medicines
ONC
#635
Rank
A$54.97 B
Marketcap
A$496.76
Share price
2.11%
Change (1 day)
53.13%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$5.27 Billion

According to BeOne Medicines's latest financial reports the company's total liabilities are A$5.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BeOne Medicines - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$4.16 B25.02%
2023-12-31A$3.32 B13.5%
2022-12-31A$2.93 B-11.51%
2021-12-31A$3.31 B47.19%
2020-12-31A$2.25 B148.7%
2019-12-31A$0.90 B28.59%
2018-12-31A$0.70 B51.75%
2017-12-31A$0.46 B532.19%
2016-12-31A$73.39 M25.97%
2015-12-31A$58.26 M71.2%
2014-12-31A$34.03 M-39.92%
2013-12-31A$56.64 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Onconova Therapeutics
ONTX
A$18.31 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
A$1.03 B-80.30%๐Ÿ‡บ๐Ÿ‡ธ USA